Exercise May Keep Muscles Fighting Cancer, New Study Finds

Muscle does more than move the body. It may also act as a quiet defender against cancer, releasing tiny particles loaded with a tumor-slowing molecule. As muscle weakens with age, that defense fades. Encouragingly, exercise switched that defense back on in older mice.

Researchers have long noticed that physically active people tend to face lower cancer risk, but the reason stayed murky. Now, a new study led by scientists at Duke-NUS Medical School in Singapore, published in Nature Communications, offers a possible mechanism. In flies and mice, muscle releases microscopic packages called extracellular vesicles. Healthy muscle packs those vesicles with a molecule that helps keep tumors in check. Aged muscle sends out fewer packages, and the ones it does send carry far less of that cargo.

Because the findings come from animal studies and laboratory experiments rather than people, whether the same effects occur in humans remains an open question. But the study draws a clear line from muscle health to tumor growth, and points to exercise as a lever worth pulling.

How Exercise And Muscle Health Connect To Cancer

At the heart of the system is a molecule called miR-7a-5p, a genetic messenger tucked inside the vesicles that healthy muscle releases. When cancer cells absorbed these packages in lab tests, the molecule slowed their growth by blocking a protein, TEAD1, that tumors lean on to multiply.

Researchers tested the idea in multiple species. In fruit flies, a common model for aging research because of their short lifespans, young muscle held intestinal overgrowth in check while aged muscle did not. Cut off the muscle’s ability to release vesicles, and the gut damage worsened.

In mice, researchers collected vesicles from healthy muscle cells and from cells deliberately damaged to mimic aging, then applied them to several cancer types. Healthy-muscle vesicles suppressed the growth of colorectal, lung, and bile duct cancer cells. Damaged-muscle vesicles did almost nothing. They also showed little or no uptake or effect in prostate cancer and neuroblast cells, suggesting muscle’s protective effects may be limited to certain tissues.

To test living animals, the team implanted human colorectal cancer into mice and compared young animals against mice 12 to 15 months old, an age at which they showed clear muscle loss and weakness. Each group used six mice. Tumors grew far larger in the older animals. When researchers chemically blocked vesicle release in young mice, their tumors ballooned to match those in old mice. Restoring the packages reversed it. In a separate strain bred to develop intestinal tumors on its own, dosing the mice with healthy-muscle vesicles cut both the number and size of tumors.

The Chain Of Command Inside Aging Muscle

Why does old muscle stop producing these packages? Researchers traced it to a protein called SDC2, part of the cellular machinery that builds and ships the vesicles. SDC2 drops sharply in aging mouse muscle. Without enough of it, the muscle cannot assemble the packages, and the cancer-slowing cargo never reaches a tumor.

SDC2 takes orders from a signaling system called Notch, which works like a control switch for cell activity. Young muscle keeps Notch active and SDC2 high. As muscle ages, Notch quiets down, SDC2 falls, and the defense goes dark.

That is where movement enters. Using treadmill and wheel exercise, the team found that physical activity in old mice reawakened Notch, raised SDC2, restarted vesicle production, refilled the cargo, and slowed tumor growth. Block Notch in those exercising mice, and every benefit vanished, supporting that pathway as a key mediator. Researchers also delivered SDC2 directly into aged muscle through gene therapy and got the same result without a treadmill, suggesting more than one route to the same end.

What The Exercise And Cancer Findings Mean For People

Age-related muscle loss, or sarcopenia, already carries a grim reputation, tied to falls, frailty, and worse outcomes during cancer treatment. A human dataset cited in the study found that people with pre-existing sarcopenia had a higher risk of developing lung, colorectal, gastric, pancreatic, and esophageal cancers, though notably not prostate cancer, the same tissue pattern the lab work showed. That dataset is observational and cannot prove muscle loss causes cancer.

As a next step, the authors suggest the Notch-SDC2 system could eventually be targeted through exercise, drugs, or gene-based therapies to help prevent or treat cancer. They also propose measuring miR-7a-5p in muscle-derived vesicles from people with and without muscle loss to see whether the same mechanism exists in humans.

For now, the takeaway sits in animals and cell cultures: muscle appears to actively fight tumors, that ability erodes with age, and exercise can restore it. Whether the same holds true in people remains the open question, but the study gives a concrete reason to keep muscle strong as the years add up.

---